ScholarIQanswers from OpenAlex & ORCID
George E. Georges
ResearcherPublications, citations & collaboration network
George E. Georges is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does George E. Georges have?
ScholarIQindexed works
George E. Georges has 180 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does George E. Georges have?
ScholarIQcitation count
George E. Georges has 7,245 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of George E. Georges?
ScholarIQh-index
George E. Georges has an h-index of 37 in OpenAlex.
What is the i10-index of George E. Georges?
ScholarIQi10-index
George E. Georges has an i10-index of 73 in OpenAlex.
What is the ORCID of George E. Georges?
ScholarIQorcid
The ORCID for George E. Georges is on the source record.
What is the OpenAlex record for George E. Georges?
ScholarIQopenalex
The OpenAlex for George E. Georges is on the source record.
What are the most-cited papers on George E. Georges?
ScholarIQmost cited works
Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects
Peter A. McSweeney, Dietger Niederwieser, Judith A. Shizuru, Brenda M. Sandmaier, Arthur J. Molina, David G. Maloney, Thomas R. Chauncey, Theodore A. Gooley, Ute Hegenbart, Richard A. Nash, Jerald P. Radich, John L. Wagner, Steven T. Minor, Frederick R. Appelbaum, William Bensinger, Eileen Bryant, Mary E.D. Flowers, George E. Georges, F. Carl Grumet, Hans‐Peter Kiem, Beverly Torok‐Storb, Cong Yu, Karl G. Blume, Rainer Storb
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
Keith Sullivan, Ellen Goldmuntz, Lynette Keyes-Elstein, Peter A. McSweeney, Ashley Pinckney, Beverly Welch, Maureen D. Mayes, Richard A. Nash, Leslie J. Crofford, Barry Eggleston, Sharon Castina, Linda M. Griffith, Julia Goldstein, Dennis Wallace, Oana Craciunescu, Dinesh Khanna, Rodney J. Folz, Jonathan Goldin, E. William St. Clair, James R. Seibold, Kristine Phillips, Shin Mineishi, Robert W. Simms, Karen K. Ballen, Mark H. Wener, George E. Georges, Shelly Heimfeld, Chitra Hosing, Stephen J. Forman, Suzanne Kafaja, Richard M. Silver, Leroy Griffing, Jan Storek, Sharon LeClercq, Richard Brasington, Mary Ellen Csuka, Christopher Bredeson, Carolyn A. Keever-Taylor, Robyn T. Domsic, M. Bashar Kahaleh, Thomas A. Medsger, Daniel E. Furst
Animal Models for Medical Countermeasures to Radiation Exposure
Jacqueline P. Williams, Stephen L. Brown, George E. Georges, Martin Hauer‐Jensen, Rićhard P. Hill, Amy K. Huser, David G. Kirsch, Thomas J. MacVittie, Kathy A. Mason, Meetha Medhora, John E. Moulder, Paul Okunieff, Mary F. Otterson, Michael E. Robbins, James B. Smathers, William H. McBride
Long-term Outcomes Among Older Patients Following Nonmyeloablative Conditioning and Allogeneic Hematopoietic Cell Transplantation for Advanced Hematologic Malignancies
Mohamed L. Sorror, Brenda M. Sandmaier, Barry E. Storer, Georg‐Nikolaus Franke, Ginna G. Laport, Thomas R. Chauncey, Edward Agura, Richard T. Maziarz, Amelia Langston, Parameswaran Hari, Michael A. Pulsipher, Wolfgang Bethge, Firoozeh Sahebi, Benedetto Bruno, Michael B. Maris, Andrew M. Yeager, Finn Bo Petersen, Lars L. Vindeløv, Peter A. McSweeney, Kai Hübel, Marco Mielcarek, George E. Georges, Dietger Niederwieser, Karl G. Blume, David G. Maloney, Rainer Storb
Long-term Outcomes After Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis
Paolo A. Muraro, Marcelo C. Pasquini, Harold Atkins, James D. Bowen, Dominique Farge, Αthanasios Fassas, Mark S. Freedman, George E. Georges, Francesca Gualandi, Nelson Hamerschlak, Eva Havrdová, Vasilios Κ. Kimiskidis, Tomáš Kozák, Giovanni L. Mancardi, Luca Massacesi, Daniela A. Moraes, Richard A. Nash, Steven Z. Pavletic, Jian Ouyang, Montserrat Rovira, Albert Saiz, Belinda Pinto Simões, Marek Trněný, Lin Zhu, Manuela Badoglio, Xiaobo Zhong, Maria Pia Sormani, Riccardo Saccardi, for the Multiple Sclerosis–Autologous Hematopoietic Stem Cell Transplantation (MS-AHSCT) Long-term Outcomes Study Group